ANNUAL MEETING OF STOCKHOLDERS AUGUST 17, 2021

Company

BioRestorative Therapies, Inc.

Filed

July 7, 2021

Period of Report

August 17, 2021

Accession Number

0001021771-21-000049

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →